| P2093 | author name string | Ping Zhang | |
| | Qian Jiang | |
| | Dong-xia Ye | |
| | Lai-ping Zhong | |
| | Zhi-yuan Zhang | |
| | Hong-ya Pan | |
| P2860 | cites work | ras p21 expression in the progression of breast cancer | Q68204054 |
| | Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines | Q73420356 |
| | Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma | Q77193465 |
| | Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients | Q79101785 |
| | Oral and maxillofacial surgeons treating oral cancer: a preliminary report from the American Association of Oral and Maxillofacial Surgeons Task Force on Oral Cancer | Q82263577 |
| | Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 |
| | Downregulation of tapasin expression in progressive human malignant melanoma | Q28189544 |
| | Tapasin: an ER chaperone that controls MHC class I assembly with peptide | Q28207406 |
| | Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum | Q28219269 |
| | The mechanism of action of tapasin in the peptide exchange on MHC class I molecules determined from kinetics simulation studies | Q28241100 |
| | Gene silencing in cancer in association with promoter hypermethylation | Q29617274 |
| | Different regulation of MHC class I antigen processing components in human tumors | Q30319116 |
| | Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules | Q30446891 |
| | Antigen-processing machinery breakdown and tumor growth | Q34011098 |
| | Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy. | Q34583210 |
| | Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells | Q35136002 |
| | HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma | Q36184723 |
| | Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance | Q36290298 |
| | Epigenetics provides a new generation of oncogenes and tumour-suppressor genes | Q36365099 |
| | Epigenetic regulation of immune escape genes in cancer | Q36471068 |
| | Epigenetic remodelling of DNA in cancer | Q36911624 |
| | HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance | Q37287152 |
| | IFN inducibility of major histocompatibility antigens in tumors | Q37341021 |
| | Enhancement of apoptotic damage of squamous cell carcinoma cells by inhibition of the mitochondrial DNA repairing system | Q39934736 |
| | Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. | Q40009864 |
| | Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER. | Q40201200 |
| | Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells | Q40285760 |
| | Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL. | Q40308525 |
| | Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine | Q40362047 |
| | Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival | Q40377771 |
| | Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome | Q40438087 |
| | A transmembrane tail: interaction of tapasin with TAP and the MHC class I molecule | Q41272865 |
| | Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment | Q43773475 |
| | Methylation-regulated expression of HLA class I antigens in melanoma | Q44409607 |
| | MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma | Q44747139 |
| | Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer | Q46594789 |
| | Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer | Q52162412 |
| | HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. | Q53598603 |
| P433 | issue | 5 | |
| P921 | main subject | oral squamous cell carcinoma | Q18553522 |
| P304 | page(s) | 451-459 | |
| P577 | publication date | 2010-06-08 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome | |
| P478 | volume | 31 | |